Whippany-based Bayer announced on April 20 that two of its top pharmaceutical executives, Nelson Ambrogio and John Berrios, will take on new leadership roles within the division to advance its ...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced key ...

RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (FRX:CA), a commercial stage specialty pharmaceutical company, today announced that it has strengthened its ...

RPG Life Sciences Limited ( ($IN:RPGLIFE) ) has shared an announcement. RPG Life Sciences Limited announced significant strategic decisions ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...

FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today ...

FORT WORTH, Texas, Dec. 05, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products ...

FIP fellowship recognizes individual members of FIP who have exhibited strong leadership internationally, distinguished themselves in the pharmaceutical sciences and/or practice of pharmacy, ...

Beginning seven years ago when the Associated Press released a report that revealed trace amounts of pharmaceuticals were found in the drinking water used by at least 46 million Americans, hospitals ...

X4 Pharmaceuticals’ consensus analyst price target has recently decreased from $8.70 to $7.38, reflecting a more cautious outlook on expected returns. This adjustment is primarily attributed to ...

WALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Edward (Ted) Myles, Chief Financial and Chief Operating Officer, is leaving the Company ...